Patent ID: 8911342

Claim:
A non-invasive method for the treatment, relief or prophylaxis of a condition selected from the group consisting of Depression, Major Depressive Disorder, Bipolar Disorder, Epilepsy, Parkinson's Disease and Alzheimer's Disease, or for alleviating one or more symptoms associated therewith in a subject, said method comprising: applying a pulsed electromagnetic field trans-cranially at least to the hippocampus of said subject concomitant with administration to said subject of an antidepressant substance or compound, wherein said antidepressant substance or compound is selected from the group consisting of a serotonin-norepinephrine reuptake inhibitor (SNRI) and a selective serotonin reuptake inhibitor (SSRI), and wherein said pulsed electromagnetic field is applied with a frequency between 3-1000 Hz and a maximum field strength falls in the interval 0.02-2 V/m at a distance of 1 cm from at least one electrically conducting coil used to generate the electromagnetic field.